Disclosures for "Intermuscular Coherence as a Biomarker for Primary Lateral Sclerosis"
-
Dr. Issa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CVS/Caremark. The institution of Dr. Issa has received research support from NIH. Dr. Issa has received intellectual property interests from a discovery or technology relating to health care. Dr. Issa has a non-compensated relationship as a Scientific advisory board member with Theta Neurotech that is relevant to AAN interests or activities.
-
Ms. Badillo-Goicoechea has nothing to disclose.
-
Author has nothing to disclose
-
Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for inThought.
-
Dr. Carberry has nothing to disclose.
-
Dr. Ho has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals.
-
Dr. Garret has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Advarra. The institution of Dr. Garret has received research support from Biogen. The institution of Dr. Garret has received research support from Target ALS. The institution of Dr. Garret has received research support from uniQure. The institution of Dr. Garret has received research support from Mass General Brigham. The institution of Dr. Garret has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Garret has received research support from NIH/NINDS. Dr. Garret has received research support from FDA. Dr. Garret has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant with Massachusetts Department of Health.
-
Mr. Moses has nothing to disclose.
-
Dr. Soliven has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CVS Pharmacy. The institution of Dr. Soliven has received research support from NIH. The institution of Dr. Soliven has received research support from NIH. The institution of Dr. Soliven has received research support from Alexion. The institution of Dr. Soliven has received research support from Roche/Genentech.
-
Dr. Rezania has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Akcea. Dr. Rezania has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alnylam.